202 related articles for article (PubMed ID: 34407232)
1. Dapagliflozin and xanthine oxidase inhibitors improve insulin resistance and modulate renal glucose and urate transport in metabolic syndrome.
Ng HY; Leung FF; Kuo WH; Lee WC; Lee CT
Clin Exp Pharmacol Physiol; 2021 Dec; 48(12):1603-1612. PubMed ID: 34407232
[TBL] [Abstract][Full Text] [Related]
2. Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome.
Ng HY; Kuo WH; Tain YL; Leung FF; Lee WC; Lee CT
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836340
[TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.
Stack AG; Han D; Goldwater R; Johansson S; Dronamraju N; Oscarsson J; Johnsson E; Parkinson J; Erlandsson F
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2347-e2356. PubMed ID: 33075806
[TBL] [Abstract][Full Text] [Related]
4. A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn
Olgar Y; Turan B
Can J Physiol Pharmacol; 2019 Jun; 97(6):528-535. PubMed ID: 30444646
[TBL] [Abstract][Full Text] [Related]
5. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model.
Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak L; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Effects of Febuxostat and Allopurinol in an Animal Model of Metabolic Syndrome.
Nadwa EH; Morcos GNB; Salama NM; Shafik AN
Pharmacology; 2021; 106(9-10):564-572. PubMed ID: 34182567
[TBL] [Abstract][Full Text] [Related]
7. Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity.
Hou CW; Lee YC; Hung HF; Fu HW; Jeng KC
Am J Chin Med; 2012; 40(5):979-91. PubMed ID: 22928829
[TBL] [Abstract][Full Text] [Related]
8. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.
Han S; Hagan DL; Taylor JR; Xin L; Meng W; Biller SA; Wetterau JR; Washburn WN; Whaley JM
Diabetes; 2008 Jun; 57(6):1723-9. PubMed ID: 18356408
[TBL] [Abstract][Full Text] [Related]
10. Alterations of Renal Epithelial Glucose and Uric Acid Transporters in Fructose Induced Metabolic Syndrome.
Ng HY; Lee YT; Kuo WH; Huang PC; Lee WC; Lee CT
Kidney Blood Press Res; 2018; 43(6):1822-1831. PubMed ID: 30537749
[TBL] [Abstract][Full Text] [Related]
11. Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors.
Packer M
J Card Fail; 2020 Nov; 26(11):977-984. PubMed ID: 32890737
[TBL] [Abstract][Full Text] [Related]
12. Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats.
Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak LO; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
Diabetes Obes Metab; 2018 Nov; 20(11):2617-2626. PubMed ID: 29923295
[TBL] [Abstract][Full Text] [Related]
13. Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules.
Kim JH; Ko HY; Wang HJ; Lee H; Yun M; Kang ES
Diabetes Obes Metab; 2020 Mar; 22(3):373-382. PubMed ID: 31692240
[TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
Tanday N; Irwin N; Flatt PR; Moffett RC
Biochem Pharmacol; 2020 Jul; 177():114009. PubMed ID: 32360307
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
Terami N; Ogawa D; Tachibana H; Hatanaka T; Wada J; Nakatsuka A; Eguchi J; Horiguchi CS; Nishii N; Yamada H; Takei K; Makino H
PLoS One; 2014; 9(6):e100777. PubMed ID: 24960177
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
Shin SJ; Chung S; Kim SJ; Lee EM; Yoo YH; Kim JW; Ahn YB; Kim ES; Moon SD; Kim MJ; Ko SH
PLoS One; 2016; 11(11):e0165703. PubMed ID: 27802313
[TBL] [Abstract][Full Text] [Related]
17. Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability.
Díaz-Rodríguez E; Agra RM; Fernández ÁL; Adrio B; García-Caballero T; González-Juanatey JR; Eiras S
Cardiovasc Res; 2018 Feb; 114(2):336-346. PubMed ID: 29016744
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats.
Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
Clin Sci (Lond); 2019 Dec; 133(23):2415-2430. PubMed ID: 31769484
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin attenuates renal gluconeogenic enzyme expression in obese rats.
Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
J Endocrinol; 2020 May; 245(2):193-205. PubMed ID: 32092034
[TBL] [Abstract][Full Text] [Related]
20. Effects of dapagliflozin on peripheral sympathetic nerve activity in standard chow- and high-fat-fed rats after a glucose load.
Sato D; Nakamura T; Amarume J; Yano M; Nishina A; Feng Z; Kusunoki M
J Pharmacol Sci; 2022 Jan; 148(1):86-92. PubMed ID: 34924134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
